Selective killing of cancer cells via simultaneous destabilization of mitochondrial iron metabolism and induction of ferroptosis elicited by mitochondrially targeted iron chelator deferasirox
S. B. Jadhav, C. Sandoval Acuna, Y. Pacior Pampin, K. Klanicova, K. Blazkova, R. Sedlacek, J. Stursa, L. Werner, J. Truksa
This study introduces mitoDFX, a mitochondrially targeted iron chelator that simultaneously depletes iron and induces ferroptosis, showing high selectivity and efficacy against cancer cells.
bioRxiv · Jan 17, 2024 · PreprintCancer Biology